Lucid Diagnostics Inc. (LUCD) Tops Q3 EPS by 1c

Lucid Diagnostics Inc. (NASDAQ: LUCD) reported Q3 EPS of ($0.10), $0.01 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $1.21 million versus the consensus estimate of $1.36 million.

For earnings history and earnings-related data on Lucid Diagnostics Inc. (LUCD) click here.

You May Also Be Interested In

• ServiceNow (NOW) call put ratio 3.8 calls to 1 put with a focus on 1200 contracts of July 116 calls
• Morgan Stanley (MS) call put ratio 1.4 calls to 1 put into quarter results
• Accenture (ACN) call put ratio 2 calls to 1 put as share price down 3%